Biotech Valuation Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation

CRSP 56.25

-0.8%

3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: Doc Bones	11/19/2004 8:53:32 AM
	Read Replies (1) of 52153

Biogen May Take Hits on MS Drug HEARD ON THE STREET The FDA is widely expected to approve Biogen Idec's new drug for multiple sclerosis before the end of this month. That isn't necessarily good news for Biogen shareholders. This is all I can get for now because: NOTICE TO OUR USERS: The Wall Street Journal Online and Barron's Online are unavailable due to technical difficulties. We apologize for the inconvenience. The very high quality of information available at wsj.com [highly recommended] is not matched by the quality of the internet site. A few days ago it was crashing Explorer every time I logged on [crashing in flash.ocx - for those 'wonderful' moving ads - I knew BLINK would come back to haunt us.] Doc

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next